BioSpace News Archive

Anixa Biosciences, Inc., a biotechnology company focused on the treatment, prevention, and diagnosis of cancer and infectious diseases, announced the publication of a peer-reviewed journal article in Biomarker Insights.

Compugen Ltd., a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, announced that the Company will release its first quarter 2020 financial results on Wednesday, May 6, 2020 before the U.S. financial markets open.

$52 million is being allocated to progress IND-enabling studies in adrenomyeloneuropathy (AMN) and grow the pipeline in rare, monogenic neurological diseases

NiKang is eligible to receive an upfront collaboration fee and milestone payments of more than $100 million plus royalties on future net product sales

Conformis, Inc. announced that, due in large part to a loan made available to the Company under the Paycheck Protection Program offered by the U.S. Small Business Administration to qualified small businesses in response to the coronavirus pandemic and the economic harm done to the Company’s business, the Company has accelerated its plan to return to full-time employment the vast majority of those employees who were furloughed on March 23, 2020.

Two Virtual Posters Highlight New ANJESO Clinical Results, Along with Health Resource Utilization Data, When Administered Preoperatively Following Total Knee Arthroplasty

MedMira Inc., announced that it had submitted the notification for the Emergency Use Authorization application offered by the U.S. Food and Drug Administration for its newest member of its Reveal line of products for antibody testing.

CareDx and Johns Hopkins Announce Mobile Health Partnership with RemoTraC Use Among Lung Transplant Patients

Bausch Health Companies Inc. will release its first-quarter 2020 financial results on Thursday, May 7, 2020.